| Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study M May, M Gompels, V Delpech, K Porter, F Post, M Johnson, D Dunn, ... Bmj 343, 2011 | 492 | 2011 |
| Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models BL Jewell, E Mudimu, J Stover, D Ten Brink, AN Phillips, JA Smith, ... The lancet HIV 7 (9), e629-e640, 2020 | 447 | 2020 |
| When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study HIV-CAUSAL Collaboration* Annals of internal medicine 154 (8), 509-515, 2011 | 353 | 2011 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 295 | 2005 |
| Sustainable HIV treatment in Africa through viral-load-informed differentiated care A Phillips, A Shroufi, L Vojnov, J Cohn, T Roberts, T Ellman, K Bonner, ... Nature 528 (7580), S68-S76, 2015 | 178 | 2015 |
| Outcome in renal Al amyloidosis after chemotherapy JH Pinney, HJ Lachmann, L Bansi, AD Wechalekar, JA Gilbertson, ... Journal of clinical oncology 29 (6), 674-681, 2011 | 174 | 2011 |
| Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication W Stöhr, D Back, D Dunn, C Sabin, A Winston, R Gilson, D Pillay, T Hill, ... Antiviral therapy 13 (5), 675-685, 2008 | 160 | 2008 |
| Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study AN Phillips, F Venter, D Havlir, A Pozniak, D Kuritzkes, A Wensing, ... The lancet HIV 6 (2), e116-e127, 2019 | 129 | 2019 |
| Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium B Neesgaard, L Greenberg, JM Miró, K Grabmeier-Pfistershammer, ... The lancet HIV 9 (7), e474-e485, 2022 | 106 | 2022 |
| Late diagnosis in the HAART era: proposed common definitions and associations with mortality. CA Sabin, A Schwenk, MA Johnson, B Gazzard, M Fisher, J Walsh, ... AIDS (London, England) 24 (5), 723-727, 2010 | 104 | 2010 |
| Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study RK Lodwick, CA Sabin, K Porter, B Ledergerber, A Van Sighem, ... The Lancet 376 (9738), 340-345, 2010 | 100 | 2010 |
| Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe A De Luca, D Dunn, M Zazzi, R Camacho, C Torti, I Fanti, R Kaiser, ... The Journal of infectious diseases 207 (8), 1216-1220, 2013 | 97 | 2013 |
| CD4 counts and the risk of systemic non-Hodgkin’s lymphoma in individuals with HIV in the UK M Bower, M Fisher, T Hill, I Reeves, J Walsh, C Orkin, AN Phillips, L Bansi, ... haematologica 94 (6), 875, 2009 | 89 | 2009 |
| Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure F Ibrahim, C Naftalin, E Cheserem, J Roe, LJ Campbell, L Bansi, ... Aids 24 (14), 2239-2244, 2010 | 84 | 2010 |
| Discordant responses on starting highly active antiretroviral therapy: suboptimal CD4 increases despite early viral suppression in the UK Collaborative HIV Cohort (UK CHIC) Study R Gilson, SL Man, A Copas, A Rider, S Forsyth, T Hill, L Bansi, K Porter, ... HIV medicine 11 (2), 152-160, 2010 | 82 | 2010 |
| Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an … AN Phillips, C Leen, A Wilson, J Anderson, D Dunn, A Schwenk, C Orkin, ... The Lancet 370 (9603), 1923-1928, 2007 | 76 | 2007 |
| Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines AN Phillips, L Bansi-Matharu, F Venter, D Havlir, A Pozniak, DR Kuritzkes, ... The Lancet HIV 7 (3), e193-e200, 2020 | 62 | 2020 |
| Rates of subsequent surgery following endometrial ablation among E nglish women with menorrhagia: population‐based cohort study L Bansi‐Matharu, I Gurol‐Urganci, TA Mahmood, A Templeton, ... BJOG: An International Journal of Obstetrics & Gynaecology 120 (12), 1500-1507, 2013 | 62 | 2013 |
| Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations* L Bansi, C Sabin, V Delpech, T Hill, M Fisher, J Walsh, T Chadborn, ... HIV medicine 11 (7), 432-438, 2010 | 62 | 2010 |
| Clinical epidemiology of HIV-associated end-stage renal failure in the UK L Bansi, A Hughes, S Bhagani, NE Mackie, C Leen, J Levy, S Edwards, ... Aids 23 (18), 2517-2521, 2009 | 62 | 2009 |
Andrew PhillipsUniversity College London (UCL)Overená e-mailová adresa na: ucl.ac.uk
